相关实验视频

Updated: May 24, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

对头癌患者的肺癌监测

Naif Fnais¹, Francisco Laxague², Marco A Mascarella³

¹Department of Otolaryngology-Head and Neck Surgery, King Saud University, Riyadh, Saudi Arabia.

JAMA otolaryngology-- head & neck surgery

|March 6, 2025

概括

低剂量计算机断层扫描 (LDCT) 显著改善了头角状细胞癌 (HNSCC) 患者的肺转移和第二原发性肺癌的检测. 然而,目前的查方法并没有显示出生存益处.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
肺部病理学肺部病理学

背景情况:

患有头部和部状细胞癌 (HNSCC) 的患者患肺转移和二次肺癌的风险增加.
在HNSCC患者中,肺癌查的生存益处没有得到很好的确立,初始阶段是负的.

研究的目的:

为了比较胸部X射线扫描与低剂量计算机断层扫描 (LDCT) 的有效性,用于查HNSCC患者的肺转移和第二原发性肺癌.
评估这些查方法对长期癌症生存结果的影响.

主要方法:

一项随机并行试验,涉及137名未接受过治疗的HNSCC患者,这些患者不符合美国国家综合癌症网络 (NCCN) 肺部查标准.
参与者被随机分配到胸部X射线图或LDCT查.
分析了肺癌检测率,整体存活率和无病存活率的数据.

主要成果:

与胸部X射线相比,LDCT在检测肺转移和第二次原发性肺癌方面表现出更高的灵敏度 (100%) 和特异性 (100%) (灵敏度为66.7%,特异性为100%).
尽管LDCT的检测率更高,但两组之间没有观察到总体存活率或无病存活率的显著差异.
在研究期间,6.5%的患者出现了第二次原发性肺癌或肺转移.

结论:

在检测HNSCC患者肺部并发症方面,LDCT显著比胸部放射更为敏感.
虽然LDCT提高了诊断准确度,但该试验的现有证据不支持这特定患者群体中任何查方法的生存益处.
这些发现为临床医生做出关于HNSCC患者肺部查方案的决定提供了宝贵的信息.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...